Skip to main navigation Skip to search Skip to main content

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine

  • Gyu Ri Kim
  • , Eun Young Kim
  • , Si Hyun Kim
  • , Hae Kyung Lee
  • , Jaehyeon Lee
  • , Jong Hee Shin
  • , Young Ree Kim
  • , Sae Am Song
  • , Joseph Jeong
  • , Young Uh
  • , Yu Kyung Kim
  • , Dongeun Yong
  • , Hyun Soo Kim
  • , Sunjoo Kim
  • , Young Ah Kim
  • , Kyeong Seob Shin
  • , Seok Hoon Jeong
  • , Namhee Ryoo
  • , Jeong Hwan Shin*
  • *Corresponding author for this work
  • Inje University
  • Semyung University
  • The Catholic University of Korea
  • Chonnam National University
  • Jeju National University
  • University of Ulsan
  • Yonsei University Wonju
  • Kyungpook National University
  • Yonsei University
  • Hallym University
  • Gyeongsang National University
  • National Health Insurance Corporation Ilsan Hospital
  • Chungbuk National University
  • Keimyung University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Background: Streptococcus pneumoniae is a serious pathogen causing various infections in humans. We evaluated the serotype distribution and antimicrobial resistance of S. pneumoniae causing invasive pneumococcal disease (IPD) after introduction of pneumococcal conjugate vaccine (PCV)13 in Korea and investigated the epidemiological characteristics of multidrug-resistant (MDR) isolates. Methods: S. pneumoniae isolates causing IPD were collected from 16 hospitals in Korea between 2017 and 2019. Serotyping was performed using modified sequential multiplex PCR and the Quellung reaction. Antimicrobial susceptibility tests were performed using the broth microdilution method. Multilocus sequence typing was performed on MDR isolates for epidemiological investigations. Results: Among the 411 S. pneumoniae isolates analyzed, the most prevalent serotype was 3 (12.2%), followed by 10A (9.5%), 34 (7.3%), 19A (6.8%), 23A (6.3%), 22F (6.1%), 35B (5.8%), 11A (5.1%), and others (40.9%). The coverage rates of PCV7, PCV10, PCV13, and pneumococcal polysaccharide vaccine (PPSV)23 were 7.8%, 7.8%, 28.7%, and 59.4%, respectively. Resistance rates to penicillin, ceftriaxone, erythromycin, and levofloxacin were 13.1%, 9.2%, 80.3%, and 4.1%, respectively. MDR isolates accounted for 23.4% of all isolates. Serotypes 23A, 11A, 19A, and 15B accounted for the highest proportions of total isolates at 18.8%, 16.7%, 14.6%, and 8.3%, respectively. Sequence type (ST)166 (43.8%) and ST320 (12.5%) were common among MDR isolates. Conclusions: Non-PCV13 serotypes are increasing among invasive S. pneumoniae strains causing IPD. Differences in antimicrobial resistance were found according to the specific serotype. Continuous monitoring of serotypes and antimicrobial resistance is necessary for the appropriate management of S. pneumoniae infections.

Original languageEnglish
Pages (from-to)45-54
Number of pages10
JournalAnnals of Laboratory Medicine
Volume43
Issue number1
DOIs
StatePublished - 2023.01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bacterial
  • Drug resistance
  • Multiple drug resistance
  • Mutlilocus sequence typing
  • Serotyping
  • Streptococcus pneumoniae

Quacquarelli Symonds(QS) Subject Topics

  • Medicine
  • Biological Sciences

Fingerprint

Dive into the research topics of 'Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine'. Together they form a unique fingerprint.

Cite this